We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urine Test Determines Effects of Aspirin on Platelets

By Labmedica staff writers
Posted on 12 Feb 2008
A simple urine test measures the level of thromboxane production (aspirin's target) and determines the effect of aspirin on platelets. More...
The higher the levels of thromboxane, the stickier the blood platelets, and the less impact the aspirin is having. This important information allows physicians to individualize patients' therapy.

Called the AspirinWorks test, it requires only a urine sample that can be obtained in any doctor's office, making the test easy for both the physician and the patient. Other tests require freshly drawn blood that must be evaluated within at least four hours.

The AspirinWorks test is an enzyme-linked immunoassay (ELISA) that determines levels of 11-dehydro thromboxane B2 (11dhTxB2) in human urine, thus aiding the qualitative detection of aspirin effect in apparently healthy individuals post-ingestion. The test targets a potential U.S. market of over 60 million individuals and a potential global market exceeding 200 million individuals.

Launched in 2007 by Corgenix Medical Corp. (Broomfield, CO, USA) the AspirinWorks test is now available to physicians and other laboratories through Quest Diagnostics Inc. (Madison, NJ, USA).

Douglass Simpson, Corgenix' president and CEO said, "This arrangement with Quest Diagnostics is great news for the increasing number of physicians and labs wanting to offer the AspirinWorks test. Some of the nation's most prominent labs are now routinely running this important test, which determines if aspirin is eliciting an effect.”
Mr. Simpson noted that additional supporting clinical data and scientific articles scheduled for publication will further enhance the scientific and clinical validation behind aspirin effect testing.

Corgenix develops and manufactures specialized diagnostic kits for immunology disorders, vascular diseases, and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world.


Related Links:
Corgenix Medical
Quest Diagnostics

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.